drugset / Trial / NCT06398834

Esketamine and Butorphanol for Post-Lobectomy Pain

NCT06398834

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Post-thoracotomy pain syndrome (PTPS) affects respiratory function, hindering sputum clearance and ventilation, and represents a significant complication of thoracic surgery. The analgesic effect of esketamine combined with butorphanol in PTPS is still unclear, so this study focused on this aspect.

Timeline

Start
2022-03-01
Primary completion
2023-10-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.3 mg/kg Intravenous
Subject Esketamine Other / unclassified 1.5 mg/kg Intravenous
Background Butorphanol Other / unclassified 0.15 mg/kg

Indications

No indication recorded.